Clinical experience with recombinant human thrombopoietin in chemotherapy-induced thrombocytopenia-Reference-Cited by-同舟云学术

Clinical experience with recombinant human thrombopoietin in chemotherapy-induced thrombocytopenia

Published:2000-04 Issue: Volume:37 Page:28-34
ISSN:0037-1963
Container-title:Seminars in Hematology
language:en
Short-container-title:Seminars in Hematology

Author:

Vadhan-Raj Saroj

Publisher

Elsevier BV

Subject

Hematology

Reference23 articles.

1. Effects of interleukin-1α on carboplatin-induced thrombocytopenia in patients with recurrent ovarian cancer;Vadhan-Raj;J Clin Oncol,1994

2. Dose-dependent interleukin-3 stimulation of thrombopoiesis and neutropoiesis in patients with small-cell lung carcinoma before and following chemotherapy: A placebo-controlled randomized phase Ib study;D'Hondt;J Clin Oncol,1993

3. Stimulation of thrombopoiesis by recombinant human interleukin-6 (IL-6) pre-chemotherapy and postchemotherapy in previously untreated sarcoma patients with normal hematopoiesis;Demetri;Blood,1993

4. Effects of PIXY321, a granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein, on chemotherapy-induced multilineage myelosuppression in patients with sarcoma;Vadhan-Raj;J Clin Oncol,1994

5. A randomized placebo-controlled trial of recombinant human interleukin-11 in cancer patients with severe thrombocytopenia due to chemotherapy;Tepler;Blood,1996

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimal management of chemotherapy-induced thrombocytopenia with thrombopoietin receptor agonists;Blood Reviews;2024-01

2. Differential effects of recombinant human thrombopoietin on clinical outcomes in CD7-positive and CD7-negative acute myeloid leukaemia;Leukemia Research;2023-05

3. A bibliometric analysis of primary immune thrombocytopenia from 2011 to 2021;British Journal of Haematology;2023-02-20

4. Caulis Polygoni Multiflori Accelerates Megakaryopoiesis and Thrombopoiesis via Activating PI3K/Akt and MEK/ERK Signaling Pathways;Pharmaceuticals;2022-09-28

5. Avatrombopag for chemotherapy-induced thrombocytopenia in patients with non-haematological malignancies: an international, randomised, double-blind, placebo-controlled, phase 3 trial;The Lancet Haematology;2022-03